162 related articles for article (PubMed ID: 17408857)
1. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias.
Magaki S; Raghavan R; Mueller C; Oberg KC; Vinters HV; Kirsch WM
Neurosci Lett; 2007 May; 418(1):72-6. PubMed ID: 17408857
[TBL] [Abstract][Full Text] [Related]
2. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
3. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.
Merdes AR; Hansen LA; Jeste DV; Galasko D; Hofstetter CR; Ho GJ; Thal LJ; Corey-Bloom J
Neurology; 2003 May; 60(10):1586-90. PubMed ID: 12771246
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
5. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
[TBL] [Abstract][Full Text] [Related]
6. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies.
Sabbagh MN; Reid RT; Hansen LA; Alford M; Thal LJ
J Neural Transm (Vienna); 2001; 108(10):1149-57. PubMed ID: 11725817
[TBL] [Abstract][Full Text] [Related]
7. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
Kalaria RN
Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
[TBL] [Abstract][Full Text] [Related]
8. Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease.
Lippa CF; Ozawa K; Mann DM; Ishii K; Smith TW; Arawaka S; Mori H
Arch Neurol; 1999 Sep; 56(9):1111-8. PubMed ID: 10488812
[TBL] [Abstract][Full Text] [Related]
9. The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies.
Armstrong RA; Cairns NJ; Lantos PL
Exp Neurol; 1998 Mar; 150(1):122-7. PubMed ID: 9514834
[TBL] [Abstract][Full Text] [Related]
10. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
11. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
[TBL] [Abstract][Full Text] [Related]
12. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathologic Aspects of Co-occurrence of Dementia with Lewy Bodies and Alzheimer's Disease].
Takao M
Brain Nerve; 2018 Aug; 70(8):905-913. PubMed ID: 30082500
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
Shepherd CE; McCann H; Thiel E; Halliday GM
Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
[TBL] [Abstract][Full Text] [Related]
16. CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
Boström F; Hansson O; Gerhardsson L; Lundh T; Minthon L; Stomrud E; Zetterberg H; Londos E
Neurobiol Aging; 2009 Aug; 30(8):1265-71. PubMed ID: 18191875
[TBL] [Abstract][Full Text] [Related]
17. Frequency and distribution of TUNEL-positive neurons in brains of dementia with Lewy bodies: comparison with those in brains of Alzheimer's disease.
Katsuse O; Iseki E; Suzuki K; Kosaka K
Neuropathology; 2001 Dec; 21(4):272-7. PubMed ID: 11837533
[TBL] [Abstract][Full Text] [Related]
18. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.
Gearing M; Lynn M; Mirra SS
Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies.
Graham SF; Nasarauddin MB; Carey M; McGuinness B; Holscher C; Kehoe PG; Love S; Passmore AP; Elliott CT; Meharg A; Green BD
J Alzheimers Dis; 2015; 44(3):851-7. PubMed ID: 25362038
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.
Lippa CF; Smith TW; Swearer JM
Ann Neurol; 1994 Jan; 35(1):81-8. PubMed ID: 8285597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
